InvestorsHub Logo
Followers 8
Posts 249
Boards Moderated 0
Alias Born 10/10/2012

Re: jav0033 post# 260038

Tuesday, 04/09/2019 6:44:32 PM

Tuesday, April 09, 2019 6:44:32 PM

Post# of 403090
two words "Earnings Multiplier"

The average P/E ratio for the drugs sector of 24.10 is higher than the average P/E ratio for the broader health care sector, currently at 16.35. The drugs sector average is comprised of P/E ratios from a number of small-, mid- and large-cap drug manufacturers, including Biostar Pharmaceuticals (Nasdaq: BSPM) with a P/E ratio of 7.62, GlaxoSmithKline (NYSE: GSK) with a P/E ratio of 44.42 and AstraZeneca PLC (NYSE: AZN) with a P/E ratio of 74.41

if that .50 a share is inline with potential future earnings it's all about what P/E Multiplier we get.

let say on the low end .50 earning a share and a P/E of 15x (low end) = 7.5 a share for B-OM ONLY not including anything else or potential cash on hand or other partnerships or drugs in the pipeline.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News